Largest Biotechnology Industry Companies
There are 646 Biotechnology companies.
All industries.
Total Market Cap: $1.19T
Rank | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (646 stocks) | +8.47% | 20.86 | 16.03 | 0.26 | -1.98% | 5.00% | +56.62% | +10.77% | 0.90 | |||||
201 | BBOT | BridgeBio Oncology Therapeutics Inc Com | $7.75 | $570M | N/A | N/A | N/A | N/A | -13.90% | N/A | 82 | +224.00% | $25 | 0.00% | 1.37 |
202 | RIGL | Rigel Pharmaceuticals | $32.85 | $569M | N/A | 5.16 | 7.30 | N/A | 13.93% | N/A | 65 | +61.95% | $53 | -5.55% | 1.15 |
203 | ALLO | Allogene Therapeutics Inc | $1.90 | $551M | -14.18% | N/A | N/A | N/A | -19.88% | N/A | 76 | +339.47% | $8.35 | -40.45% | 1.56 |
204 | GYRE | Gyre Therapeutics Inc | $5.93 | $543M | -58.01% | N/A | 78.12 | N/A | 0.57% | N/A | 75 | +214.84% | $19 | -8.17% | 1.44 |
205 | MDXG | Mimedx Group Inc | $3.60 | $542M | N/A | 17.52 | 19.53 | 2.88 | 13.02% | N/A | 79 | +80.56% | $6.50 | -20.29% | 0.75 |
206 | TECX | AvroBio Inc | $30.28 | $528M | -34.69% | N/A | N/A | N/A | -12.42% | N/A | 77 | +159.05% | $78 | -23.39% | 1.67 |
207 | CLYM | Eliem Therapeutics Inc | $11.44 | $516M | N/A | N/A | N/A | N/A | -10.37% | N/A | 76 | +82.95% | $21 | 0.00% | 1.40 |
208 | CTMX | CytomX Therapeutics Inc | $3.01 | $516M | N/A | 19.63 | 7.43 | 0.60 | -15.59% | N/A | 83 | +315.28% | $13 | -16.10% | 2.03 |
209 | CABA | Cabaletta Bio Inc | $3.01 | $508M | +8.20% | N/A | N/A | N/A | -28.19% | N/A | 72 | +344.52% | $13 | -18.56% | 1.69 |
210 | XOMA | XOMA Corp | $41.79 | $497M | +24.19% | 14.95 | 20.28 | N/A | 1.37% | N/A | 56 | -6.68% | $39 | +5.90% | 0.93 |
211 | DNA | Ginkgo Bioworks Holdings Inc - Class A | $7.90 | $490M | N/A | N/A | N/A | N/A | -34.36% | N/A | 25 | +7.66% | $8.50 | -54.33% | 2.39 |
212 | PRME | Prime Medicine Inc | $2.78 | $489M | N/A | N/A | N/A | N/A | -32.43% | N/A | 69 | +149.37% | $6.92 | 0.00% | 2.14 |
213 | CBIO | N/A | $17.92 | $484M | +34.96% | N/A | N/A | N/A | -15.78% | N/A | 77 | +72.99% | $31 | 0.00% | 0.81 |
214 | SVA | Sinovac Biotech Ltd | $6.47 | $465M | N/A | N/A | 357.14 | N/A | N/A | 850.00% | N/A | -45.60% | $3.52 | +56.87% | N/A |
215 | KYTX | Kyverna Therapeutics Inc | $8.06 | $464M | N/A | N/A | N/A | N/A | -32.44% | N/A | 83 | +277.41% | $30 | 0.00% | 1.79 |
216 | FDMT | 4D Molecular Therapeutics Inc | $8.83 | $456M | N/A | N/A | N/A | N/A | -28.45% | N/A | 75 | +219.59% | $28 | -21.31% | 1.35 |
217 | VALN | Valneva SE | $5.36 | $453M | -3.75% | N/A | 666.67 | N/A | -18.40% | N/A | 62 | +127.82% | $12 | -28.12% | 0.97 |
218 | MRVI | Maravai LifeSciences Holdings Inc - Class A | $4.98 | $451M | N/A | N/A | 370.37 | N/A | -14.69% | N/A | 63 | +14.46% | $5.70 | -35.61% | 1.23 |
219 | ARVN | Arvinas Inc | $7.58 | $450M | +1.07% | N/A | 17.86 | N/A | -57.06% | N/A | 63 | +95.25% | $15 | -38.23% | 1.16 |
220 | NGNE | Neoleukin Therapeutics Inc | $29.10 | $437M | +11.24% | N/A | N/A | N/A | -19.02% | N/A | 75 | +174.91% | $80 | -32.77% | 1.89 |
221 | IMMX | Immix Biopharma Inc | $8.45 | $434M | N/A | N/A | N/A | N/A | -7.56% | N/A | 87 | +118.46% | $18 | 0.00% | 1.27 |
222 | STRO | Sutro Biopharma Inc | $28.80 | $432M | +18.47% | N/A | 10.03 | N/A | -35.08% | N/A | 72 | +67.74% | $48 | -31.58% | 1.51 |
223 | AURA | Aura Biosciences Inc | $6.41 | $430M | N/A | N/A | N/A | N/A | -19.79% | N/A | 79 | +193.29% | $19 | 0.00% | 1.15 |
224 | CTNM | Contineum Therapeutics Inc - Class A | $11.88 | $422M | N/A | N/A | N/A | N/A | -13.67% | N/A | 75 | +87.96% | $22 | 0.00% | 0.75 |
225 | PRTA | Prothena Corporation plc | $8.25 | $420M | -1.54% | N/A | 10.63 | N/A | -19.37% | N/A | 62 | +159.39% | $21 | -29.58% | 0.95 |
226 | CYBN | Cybin Inc | $8.28 | $408M | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +480.19% | $48 | -31.92% | 0.93 |
227 | AVTX | Avalo Therapeutics Inc | $14.76 | $404M | N/A | N/A | N/A | N/A | -12.74% | N/A | 78 | +206.57% | $45 | -72.92% | 0.55 |
228 | CCCC | C4 Therapeutics Inc | $3.90 | $403M | N/A | N/A | N/A | N/A | -23.85% | N/A | 78 | +241.79% | $13 | -37.87% | 1.81 |
229 | OCGN | Ocugen Inc | $1.21 | $403M | +8.79% | N/A | 13.07 | N/A | -14.80% | N/A | 78 | +844.63% | $11 | -27.71% | 1.76 |
230 | MNPR | Monopar Therapeutics Inc | $59.77 | $398M | -5.81% | N/A | N/A | N/A | -2.52% | N/A | 82 | +88.42% | $113 | +14.67% | 1.71 |
231 | AUTL | Autolus Therapeutics plc | $1.56 | $394M | N/A | N/A | N/A | N/A | -73.26% | N/A | 77 | +458.33% | $8.71 | -27.82% | 1.32 |
232 | YMAB | Y-Mabs Therapeutics Inc | $8.61 | $390M | N/A | N/A | N/A | N/A | -4.59% | N/A | N/A | N/A | N/A | -25.00% | N/A |
233 | IPSC | Century Therapeutics Inc | $2.25 | $382M | -16.95% | N/A | N/A | N/A | -25.08% | N/A | 75 | +111.11% | $4.75 | 0.00% | 1.65 |
234 | OVID | Ovid Therapeutics Inc | $2.30 | $381M | N/A | N/A | 1.79 | N/A | -11.00% | N/A | 75 | +137.83% | $5.47 | -12.37% | 1.47 |
235 | RVNC | Revance Therapeutics Inc | $3.65 | $380M | N/A | N/A | N/A | N/A | -53.98% | N/A | N/A | +159.45% | $9.47 | -34.38% | 0.34 |
236 | PRTC | PureTech Health plc American Depositary Shares | $17.42 | $377M | -28.22% | N/A | N/A | N/A | -58.22% | N/A | N/A | N/A | N/A | -21.32% | N/A |
237 | ALT | Altimmune Inc | $2.61 | $374M | -10.93% | N/A | 8.18 | 32.62 | -18.08% | N/A | 75 | +515.33% | $16 | -28.80% | 1.57 |
238 | RZLT | Rezolute Inc | $4 | $367M | -10.29% | N/A | N/A | N/A | -20.04% | N/A | 70 | +77.75% | $7.11 | -20.10% | 0.94 |
239 | VNDA | Vanda Pharmaceuticals Inc | $5.87 | $363M | N/A | N/A | 103.09 | N/A | -35.11% | N/A | 70 | +140.55% | $14 | -21.18% | 0.65 |
240 | UPB | Upstream Bio Inc | $6.10 | $359M | N/A | N/A | N/A | N/A | -39.09% | N/A | 78 | +527.05% | $38 | 0.00% | 1.14 |
241 | LRMR | Larimar Therapeutics Inc | $3.47 | $357M | -8.46% | N/A | N/A | N/A | -31.51% | N/A | 77 | +335.45% | $15 | -15.86% | 1.61 |
242 | PBYI | Puma Biotechnology Inc | $7.33 | $357M | N/A | 14.45 | 3.46 | 0.03 | 14.99% | N/A | 50 | -31.79% | $5 | -7.58% | 0.83 |
243 | BNTC | Benitec Biopharma Inc | $11.18 | $357M | N/A | N/A | N/A | N/A | -5.55% | N/A | 78 | +130.77% | $26 | -32.52% | 0.81 |
244 | ASMB | Assembly Biosciences Inc | $22.96 | $354M | -44.47% | N/A | 13.04 | N/A | -11.26% | N/A | 75 | +117.77% | $50 | -14.75% | 1.07 |
245 | XFOR | X4 Pharmaceuticals Inc | $4 | $352M | N/A | N/A | N/A | N/A | -26.39% | N/A | 75 | +193.75% | $12 | -56.32% | 1.47 |
246 | AVIR | Atea Pharmaceuticals Inc | $4.49 | $351M | N/A | N/A | N/A | N/A | -42.09% | N/A | 66 | +93.10% | $8.67 | -28.37% | 0.77 |
247 | EDIT | Editas Medicine Inc | $2.50 | $349M | -10.67% | N/A | N/A | N/A | -40.38% | N/A | 55 | +131.20% | $5.78 | -42.13% | 2.21 |
248 | CMPX | Compass Therapeutics Inc | $2.03 | $346M | N/A | N/A | N/A | N/A | -15.41% | N/A | 76 | +334.48% | $8.82 | -17.31% | 1.59 |
249 | OABI | OmniAb Inc | $2.27 | $345M | N/A | N/A | N/A | N/A | -7.55% | N/A | 75 | +222.91% | $7.33 | 0.00% | 1.09 |
250 | FBRX | Forte Biosciences Inc | $17.56 | $340M | N/A | N/A | N/A | N/A | -14.99% | N/A | 75 | +263.04% | $64 | -55.57% | 0.53 |